Zynex Inc Insider Trading

ZYXIQ

⊜ Compare

Last 12 months

No open-market buying or selling by insiders.

The last open-market buy by an executive or director was in Jul 2024.

Net open-market

0 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

0 / 0

executives and directors

Last open-market buy

Jul 2024

Jul 29, 2024

Get an email when ZYXIQ's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Mar 3, 2025	Daniel J Moorhead Chief Financial Officer	Sold10b5-1 plan	10,000	$7.15	72K	11%	Form 4
Feb 3, 2025	Daniel J Moorhead Chief Financial Officer	Sold10b5-1 plan	10,000	$7.68	77K	34%	Form 4
Jan 2, 2025	Daniel J Moorhead Chief Financial Officer	Sold10b5-1 plan	10,000	$7.88	79K	28%	Form 4
Dec 2, 2024	Daniel J Moorhead Chief Financial Officer	Sold10b5-1 plan	10,000	$8.08	81K	22%	Form 4
Nov 14, 2024	Thomas Sandgaard President, CEO and Chairman	Sold10b5-1 plan	2,000	$8.09	16K	<0.1%	Form 4
Nov 7, 2024 – Nov 13, 2024	Thomas Sandgaard President, CEO and Chairman	Sold10b5-1 plan 5 parts	10,000	$8.93 average	89K	<0.1%	Form 4
Nov 6, 2024	Thomas Sandgaard President, CEO and Chairman	Sold10b5-1 plan	2,000	$8.82	18K	<0.1%	Form 4

Mar 3, 202510b5-1 plan
Daniel J Moorhead
Chief Financial Officer · sold 10,000 at $7.15
72K
11% of stake
Feb 3, 202510b5-1 plan
Daniel J Moorhead
Chief Financial Officer · sold 10,000 at $7.68
77K
34% of stake
Jan 2, 202510b5-1 plan
Daniel J Moorhead
Chief Financial Officer · sold 10,000 at $7.88
79K
28% of stake
Dec 2, 202410b5-1 plan
Daniel J Moorhead
Chief Financial Officer · sold 10,000 at $8.08
81K
22% of stake
Nov 14, 202410b5-1 plan
Thomas Sandgaard
President, CEO and Chairman · sold 2,000 at $8.09
16K
<0.1% of stake
Nov 7, 2024 – Nov 13, 202410b5-1 plan
Thomas Sandgaard
President, CEO and Chairman · sold 10,000 at avg $8.93
89K
<0.1% of stake
Nov 6, 202410b5-1 plan
Thomas Sandgaard
President, CEO and Chairman · sold 2,000 at $8.82
18K
<0.1% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch ZYXIQ, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Electromedical & Electrotherapeutic Apparatus · Pick stocks to compare with ZYXIQ

CompareIntrinsic value

FONRFonar Corp

No recent price53

BLFSBiolife Solutions Inc.

No recent price61

OMOutset Medical Inc.

$4.44+6.99%25

CBLLCeribell, Inc.

$27.39-3.11%25

VASOVaso Corporation

$0.29+0.00%37

ELMDElectromed Inc.

$28.01+4.83%75

EDAPEdap Tms SA

$4.34+5.60%15

IRIXIridex Corporation

$0.72+2.86%25

Spot a number that looks wrong? Check it in ZYXIQ's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing ZYXIQ

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.